NPI: 1174586226 · SANTA ANA, CA 92705 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27,105 | $1.57M |
| 2019 | 29,209 | $1.54M |
| 2020 | 32,190 | $1.66M |
| 2021 | 29,228 | $1.46M |
| 2022 | 24,686 | $1.38M |
| 2023 | 15,415 | $2.12M |
| 2024 | 5,843 | $1.35M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 66,687 | 5,489 | $10.03M |
| A4657 | Syringe, with or without needle, each | 1,887 | 1,625 | $600K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,702 | 880 | $147K |
| J1270 | Injection, doxercalciferol, 1 mcg | 32,287 | 2,785 | $117K |
| 0250 | 2,723 | 417 | $93K | |
| J1756 | Injection, iron sucrose, 1 mg | 10,756 | 3,047 | $49K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 39,180 | 3,331 | $38K |
| 82728 | 840 | 774 | $6K | |
| 90674 | 225 | 213 | $5K | |
| 90662 | 77 | 75 | $1K | |
| 90661 | 22 | 22 | $729.52 | |
| 83540 | 1,079 | 992 | $712.97 | |
| 83970 | 946 | 879 | $211.18 | |
| G0008 | Administration of influenza virus vaccine | 96 | 91 | $129.56 |
| 85041 | 1,258 | 1,161 | $69.93 | |
| 83550 | 1,019 | 934 | $47.15 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 62 | 57 | $33.98 |
| 85048 | 1,258 | 1,161 | $15.45 | |
| 82108 | 54 | 52 | $7.41 | |
| 0634 | 621 | 43 | $0.00 | |
| 0305 | 48 | 21 | $0.00 | |
| 0821 | 71 | 64 | $0.00 | |
| 0301 | 66 | 20 | $0.00 | |
| 0636 | 690 | 48 | $0.00 | |
| 0270 | 22 | 20 | $0.00 |